Inflammatory Diseases Clinical Trials

4 recruiting

Inflammatory Diseases Trials at a Glance

8 actively recruiting trials for inflammatory diseases are listed on ClinicalTrialsFinder across 6 cities in 27 countries. The largest study group is Phase 1 with 2 trials, with the heaviest enrollment activity in Adelaide, Al Mansurah, and Algiers. Lead sponsors running inflammatory diseases studies include Gilead Sciences, Gilead Sciences, Inc, and Assistance Publique - Hôpitaux de Paris.

Browse inflammatory diseases trials by phase

Treatments under study

About Inflammatory Diseases Clinical Trials

Looking for clinical trials for Inflammatory Diseases? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Inflammatory Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Inflammatory Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

UK CARDIOvascular Immune-Mediated Inflammatory Diseases (CARDIO-IMID) Registry Study

Cardiovascular DiseasesImmune-Mediated Inflammatory Diseases
University of Manchester600 enrolled2 locationsNCT06478277
Recruiting

AutoInflammatory Disease Alliance Registry (AIDA)

UveitisStill DiseaseHereditary Autoinflammatory Diseases+5 more
University of Siena3,500 enrolled112 locationsNCT05200715
Recruiting

Evaluation of the Anti-VZV Vaccine Response of Patients With Immune-mediated Systemic Inflammatory Diseases Vaccinated in the Care Setting

Vaccination Varicella-zoster VirusImmune-mediated Systemic Inflammatory Diseases
Assistance Publique - Hôpitaux de Paris50 enrolled1 locationNCT07047053
Recruiting

REtinal Markers In Neuroinflammatory Diseases ("REMIND")

Multiple SclerosisNeuroinflammatory Diseases
University Hospital, Basel, Switzerland500 enrolled1 locationNCT06369766
Recruiting
Not Applicable

EXercise Therapy in Axial SpA, Inflammation and Biologic Therapy (ExTASI-B)

ArthritisAxial SpondyloarthrithisInflammatory Diseases
Loughborough University60 enrolled2 locationsNCT06669702
Recruiting

Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

Autoimmune DiseasesAutoinflammatory Diseases
Peking Union Medical College Hospital20,000 enrolled9 locationsNCT06417502
Recruiting
Phase 1

A Phase 1 Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of GS-5718 and to Evaluate the Effect of GS-5718 on the Pharmacokinetics of Rosuvastatin in Healthy Subjects

Inflammatory Diseases
Gilead Sciences32 enrolled1 locationACTRN12621000785808
Recruiting
Phase 1

Evaluate the Pharmacokinetics of GS-9876 in Subjects with Impaired Renal Function

Inflammatory Diseases
Gilead Sciences, Inc60 enrolled3 locationsACTRN12616001548426